Healthy male/female adults
Conditions
Interventions
Consume one test tablet by allowing it to dissolve in the mouth (on the tongue) without chewing
Consume one placebo tablet by allowing it to dissolve in the mouth (on the tongue) without chewing
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Male and female aged 40 to below 70 years at the time of consent acquisition. 2.Individuals who are aware that their mouth tends to dry out easily. 3. Individuals with a baseline resting saliva secretion of 1.5 g or more during preliminary testing. 4. Individuals who are able to give informed consent to participate in this study after receiving a detailed explanation of the protocol and understanding its contents.
Exclusion criteria
Exclusion criteria: 1. Individuals who consume foods or supplements containing dihydrocapsiate, coenzyme Q10, eriodictyol-6-C-glucoside, or similar compounds that could affect the trial, including Foods with Function Claims, functional food labels, and health supplements, more than once a week and cannot discontinue their use from the time of consent. 2. Individuals who cannot discontinue the intake of dihydrocapsiate, coenzyme Q10, eriodictyol-6-C-glucoside, or similar compounds included in Foods with Function Claims, functional food labels, and health supplements from the time of consent. 3. Individuals who are taking medications that could affect the trial, such as antihypertensives, antihistamines, antiepileptics, anti-Parkinson drugs, and sedatives. 4. Individuals who are participating in, have participated in within the four weeks prior to the current trial, or are planning to participate in clinical trials of pharmaceuticals or health foods. 5. Smokers, except for those who have abstained from smoking for more than one year. 6. Individuals with excessive alcohol intake. 7. Individuals with previous and/or current medical history of serious diseases in the heart, liver, kidney, digestive organs. 8. Females who are pregnant or lactating, and those who intend to become pregnant during the trial period. 9. Individuals with allergies to medications and/or food. 10. Individuals deemed unsuitable for participation in the trial by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Saliva secretion measurements (at rest and after test food intake) | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective assessment using the Visual Analogue Scale (VAS) | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Clinical Planning Department
Outcome results
None listed